Advertisements


Moderna says NEJM study shows COVID antibody persistence out to 6 months

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 7th, 2021

Moderna COVID-19 vaccine study shows protection lasts at least 6 months

The report Tuesday in th.....»»

Category: topSource: chicagotribuneApr 6th, 2021

New Study Shows "Long Haul" COVID-19 Can Kill Patients Months After Infection

New Study Shows "Long Haul" COVID-19 Can K.....»»

Category: blogSource: zerohedgeApr 23rd, 2021

Pfizer study shows COVID-19 vaccine still effective up to 6 months later

There were no serious safety c.....»»

Category: topSource: chicagotribuneApr 1st, 2021

A new lab study shows troubling signs that Pfizer"s and Moderna"s COVID-19 shots could be far less effective against the variant first found in South Africa

A mutation called E484K appeared to help the variant, first found in South Africa, to evade antibodies produced by the vaccines, the authors said. .....»»

Category: worldSource: nytMar 8th, 2021

CityWatch: Could antibody testing be key to reopening New York’s economy?

Most who’ve recovered from COVID-19 make antibodies capable of neutralizing the deadly virus, a study shows......»»

Category: topSource: marketwatchMay 7th, 2020

Moderna TeenCOVE study of its COVID vaccine in adolescents meets endpoint

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 25th, 2021

LabCorp study says COVID antibodies remain at least 10 months after infection

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 24th, 2021

CureVac-GSK"s Second-Gen COVID-19 Vaccine Candidate Shows Encouraging Action Against Variants In Animal Study

read more.....»»

Category: blogSource: benzingaMay 13th, 2021

: Mixing Pfizer and AstraZeneca COVID-19 vaccines increases mild side effects but is safe, study shows

Mixing doses of COVID-19 vaccines increases the risk of mild to moderate side effects when compared with administering two shots of the same vaccine, according to a U.K. trial......»»

Category: topSource: marketwatchMay 13th, 2021

Single Shot Of AstraZeneca, Pfizer COVID-19 Vaccines Provide 87% Protection, South Korea Study Shows: Reuters

read more.....»»

Category: blogSource: benzingaMay 5th, 2021

: Lilly’s COVID-19 antibody drugs are a top seller this quarter, but investors aren’t that excited

Eli Lilly's COVID-19 monoclonal antibody treatments brought in $810.1 million in global sales in the first three months of the year, but investors remain largely lukewarm about therapies that they expect to have a short lifespan......»»

Category: topSource: marketwatchApr 27th, 2021

Mild COVID-19 increases risk of death for at least 6 months in a new study of 73,000 people

People who .....»»

Category: dealsSource: nytApr 23rd, 2021

Johnson & Johnson asked other drugmakers to help it study blood-clot risks, and Moderna and Pfizer refused, report says

J&J privately contacted rival drugmakers also producing COVID-19 vaccines to join the study, and only AstraZeneca agreed, WSJ reports. Johnson & Johnson privately contacted other drugmakers producing COVID-19 vaccine to join a study into the p.....»»

Category: smallbizSource: nytApr 16th, 2021

Moderna says COVID-19 vaccine seen 90% effective against all cases at six months

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 14th, 2021

AIM ImmunoTech"s Ampligen Shows Favorable Safety Profile In Early-Stage COVID-19 Study

read more.....»»

Category: blogSource: benzingaApr 7th, 2021

U.S. government to study allergic reactions to COVID-19 vaccines

The National Institutes of Health said Wednesday that it started a clinical study assessing allergic reactions to the mRNA COVID-19 vaccines developed by Moderna Inc. and BioNTech SE /Pfizer Inc. . The aim is to understand who is.....»»

Category: topSource: marketwatchApr 7th, 2021

Over a third of COVID-19 survivors experience a neurological or mental-health condition in the 6 months after infection, a large-scale study finds

Anxiety and mood disorders were the most common neurological and mental health conditions seen in COVID survivors, a study in Lancet Psychiatry foun.....»»

Category: worldSource: nytApr 7th, 2021

Research letter indicates that Moderna"s COVID-19 vaccine has efficacy past 6 months

Shares of Moderna Inc. gained 5.9% in trading on Tuesday after research correspondence published in The New England Journal of Medicine indicates that the company's COVID-19 vaccine generated antibodies that extend.....»»

Category: topSource: marketwatchApr 6th, 2021

Trump Was Right: Sunlight Destroys COVID 8x Faster Than Scientists Believed, Study Shows

Trump Was Right: Sunlight Destroys COVID 8x Faster Than Scientists Believed, Study Shows As it turns out, President Trump might have been on to something last spring when he rambled during a press conference about the .....»»

Category: personnelSource: nytApr 2nd, 2021

Pfizer, BioNTech say study of COVID-19 patients six months after second vaccine dose proved it is safe and effective

Pfizer Inc. and German partner BioNTech SE said Thursday a study of COVI.....»»

Category: topSource: marketwatchApr 1st, 2021